Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

See original article:

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy - May 01, 2022

Correction

Correction: Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy

Online download statistics by month:

Online download statistics by month: September 2022 to March 2024

	Abstract	Full	Pdf
Sep 2022	0	139	10
Oct 2022	0	105	28
Nov 2022	0	59	14
Dec 2022	0	54	13
Jan 2023	0	37	8
Feb 2023	0	38	9
Mar 2023	0	13	1
Apr 2023	0	17	6
May 2023	0	15	3
Jun 2023	0	16	11
Jul 2023	0	17	11
Aug 2023	0	12	6
Sep 2023	0	16	9
Oct 2023	0	7	5
Nov 2023	0	24	6
Dec 2023	0	21	7
Jan 2024	0	19	4
Feb 2024	0	14	6
Mar 2024	0	17	9
Total	0	640	166